Active immunization against Lyme disease research hub

C4601003 - A PHASE 3, MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLINDED TRIAL TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY, AND LOT CONSISTENCY OF A 6-VALENT OSPA-BASED LYME DISEASE VACCINE IN HEALTHY PARTICIPANTS ≥5 YEARS OF AGE

This study is testing a new vaccine to see if it can prevent Lyme disease. Researchers want to find out how well it works, if it's safe for people aged 5 and older, and if it causes any side effects. They are also checking how the body reacts to the vaccine.